Key finding: Significantly increased lean body mass and decreased fat mass , with body composition effects comparable to exogenous GH but through pulsatile, physiological release patterns
Data in a Chinese population showed 15.1% placebo-adjusted weight reduction, with nearly 93% of treated patients achieving clinically meaningful weight loss. Chinas regulatory body has accepted ecnoglutides marketing authorization application for chronic weight management, according to the biotech
The process doesnt need to feel overwhelming
doi: 10.1210/en.2011-1895 200 VentorpF.Bay-RichterC.NagendraA
It supports healing of joint tissue, reduces inflammation, and can improve mobility
Two genes involved in gut hormones that influence appetite and digestion may be a factor in how people respond to weight loss drugs, according to a recent US study